Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast
Portfolio Pulse from
Voyager Therapeutics, Inc. (Nasdaq: VYGR) will release its Q3 2024 financial results on November 12, 2024, followed by a conference call and webcast.

November 05, 2024 | 12:30 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Voyager Therapeutics will report its Q3 2024 financial results on November 12, 2024, which could impact its stock price based on performance and future guidance.
The announcement of financial results is a significant event for any company as it provides insights into its financial health and future prospects. Investors will be looking for performance metrics and guidance that could influence the stock price. However, without specific details on expected performance, the short-term impact remains neutral until the results are disclosed.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100